Webinar Evaluation: Biologic and Biosimilar Litigation and IP Rights
Did Not Meet ExpectationsMet ExpectationsExceeded Expectations
Ease of Joining
Audio Quality
Visual Quality
1 (Poor)2 (Fair)3 (Good)4 (Excellent)5 (Superior)
Speaker Knowledge
Speaker Delivery
Topic Timeliness/Relevance
Topic Specificity
Strongly DisagreeDisagreeAgreeStrongly Agree
The cost of the program was appropriate.
The duration of the webinar and content were compatible.
The start time was convenient.

Topic Suggestions

Is there a specific topic you would like to see addressed in a future FDLI event? If so, please share your suggestions on our online portal.